The analysis showed that pharmaceutical companies penalized for paying kickbacks to doctors paid only 2.2% of their US revenue generated by the sale of the drugs that were the subject of the alleged violations. These fines covered the last 25 years. The fines were not able to disrupt the financial results of the companies. In the Czech Republic, the Ministry of Health plans to increase fines for bribes to doctors up to 3 million CZK for the first violation and to half of the annual turnover for repeated violations. Currently, companies are only threatened with fines of one hundred thousand. Recently, the company Teva Pharmaceuticals received a fine of 950,000 CZK for above-standard remuneration to doctors during the testing of the drug Fentanyl, although its worldwide sales exceeded 400 billion CZK. MPs and the ministry agree to tougher sanctions to have a deterrent effect.